Skip to content

DMAC

DiaMedica Therapeutics Inc.

NASDAQ · Healthcare · Biotechnology · US

$6.85
+0.00%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 11, 2026
EPS estimate
-$0.20
Revenue estimate
$13.5M

Latest reported

Last report date
Aug 11, 2026
EPS actual
-$0.19
EPS estimate
-$0.20
Revenue actual
Revenue estimate
$13.5M

Track record

Trailing twelve quarters

EPS beats (12Q)
5
EPS misses (12Q)
4
EPS in line (12Q)
3
Avg surprise (4Q)
-4.9%
Revenue beats (12Q)
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 11, 2026-$0.20-$0.19Beat 5.43%
May 7, 2026-$0.17-$0.19Miss -11.76%
Mar 31, 2026-$0.17-$0.17In line
Nov 12, 2025-$0.15-$0.17Miss -13.33%
Aug 12, 2025-$0.18-$0.18In line
Mar 17, 2025-$0.17-$0.18Miss -5.88%
Mar 19, 2024-$0.14-$0.14In line$30.8M
Aug 14, 2023-$0.22-$0.16Beat 27.27%
May 15, 2023-$0.16-$0.20Miss -25.00%
Nov 9, 2022-$0.13-$0.12Beat 7.69%$76.0K
Aug 10, 2022-$0.16-$0.13Beat 18.75%$13.0K
May 4, 2022-$0.20-$0.13Beat 35.00%

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026